Valiant Laboratories Limited has informed the Exchange regarding 'Intimation Recieved Under Regulation 10(5) Of SEBI (SAST) Regulations, 2011'.
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Valiant Organics Limited is acquiring 1,86,07,531 equity shares (34.26% of share capital) from Dhanvallabh Ventures LLP through an off-market transaction. The transfer is part of a restructuring exercise by Valiant Organics Limited. Post-transaction, Dhanvallabh Ventures LLP stake will reduce from 46.84% to 12.58%, while Valiant Organics Limited will hold 34.26%. Both entities are part of the promoter group. The acquirer has declared the price will not exceed 25% above the 60-day VWAP of Rs. 62.71 per share. The transaction qualifies for exemption under Regulation 10(1)(a)(iii) of SEBI SAST Regulations.
This is an internal promoter restructuring with no change in ultimate promoter control of the company. Dhanvallabh Ventures LLP significantly reduces its holding while Valiant Organics Limited becomes a major shareholder. Combined promoter holding remains substantial at around 46.84%.